These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24521012)

  • 1. miRNAs and their application in drug-induced liver injury.
    Wang Y; Chen T; Tong W
    Biomark Med; 2014; 8(2):161-72. PubMed ID: 24521012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects.
    Lin H; Ewing LE; Koturbash I; Gurley BJ; Miousse IR
    Food Chem Toxicol; 2017 Dec; 110():229-239. PubMed ID: 29042291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury.
    Shi Q; Yang X; Mendrick DL
    Biomark Med; 2013 Apr; 7(2):307-15. PubMed ID: 23547824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury.
    Sanjay S; Girish C
    Eur J Clin Pharmacol; 2017 Apr; 73(4):399-407. PubMed ID: 28028586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity.
    Yang X; Greenhaw J; Shi Q; Su Z; Qian F; Davis K; Mendrick DL; Salminen WF
    Toxicol Sci; 2012 Feb; 125(2):335-44. PubMed ID: 22112502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide miRNA-profiling of aflatoxin B1-induced hepatic injury using deep sequencing.
    Yang W; Lian J; Feng Y; Srinivas S; Guo Z; Zhong H; Zhuang Z; Wang S
    Toxicol Lett; 2014 Apr; 226(2):140-9. PubMed ID: 24472605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.
    Krauskopf J; Caiment F; Claessen SM; Johnson KJ; Warner RL; Schomaker SJ; Burt DA; Aubrecht J; Kleinjans JC
    Toxicol Sci; 2015 Feb; 143(2):268-76. PubMed ID: 25359176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Biomarkers of Toxicity in Biological Matrices.
    Harrill AH; McCullough SD; Wood CE; Kahle JJ; Chorley BN
    Toxicol Sci; 2016 Aug; 152(2):264-72. PubMed ID: 27462126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH.
    Wang Y; Liu Z; Zou W; Hong H; Fang H; Tong W
    Biomark Med; 2015; 9(11):1189-200. PubMed ID: 26506944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validation.
    Wang W; Shi Q; Mattes WB; Mendrick DL; Yang X
    Biomark Med; 2015; 9(11):1177-88. PubMed ID: 26501984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.
    Yang X; Salminen WF; Shi Q; Greenhaw J; Gill PS; Bhattacharyya S; Beger RD; Mendrick DL; Mattes WB; James LP
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):180-7. PubMed ID: 25708609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-RNAs and next generation sequencing: new perspectives in heart failure.
    Chini VP
    Clin Chim Acta; 2015 Mar; 443():114-9. PubMed ID: 25463748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity.
    Hebels DG; Jetten MJ; Aerts HJ; Herwig R; Theunissen DH; Gaj S; van Delft JH; Kleinjans JC
    Biomark Med; 2014; 8(2):185-200. PubMed ID: 24521014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of miRNAs in the early phase of halothane-induced liver injury.
    Endo S; Yano A; Fukami T; Nakajima M; Yokoi T
    Toxicology; 2014 May; 319():75-84. PubMed ID: 24598351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward predictive models for drug-induced liver injury in humans: are we there yet?
    Chen M; Bisgin H; Tong L; Hong H; Fang H; Borlak J; Tong W
    Biomark Med; 2014; 8(2):201-13. PubMed ID: 24521015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ins and outs of microRNAs as biomarkers in liver disease and transplantation.
    Farid WR; Verhoeven CJ; de Jonge J; Metselaar HJ; Kazemier G; van der Laan LJ
    Transpl Int; 2014 Dec; 27(12):1222-32. PubMed ID: 24963540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations to qualify biomarker candidates of drug-induced liver injury.
    Ozer JS; Chetty R; Kenna G; Koppiker N; Karamjeet P; Li D; Palandra J; Lanevschi A; Souberbielle BE; Ramaiah S
    Biomark Med; 2010 Jun; 4(3):475-83. PubMed ID: 20550481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review.
    Oda S; Yokoi T
    Drug Metab Pharmacokinet; 2021 Apr; 37():100372. PubMed ID: 33461055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephron segment specific microRNA biomarkers of pre-clinical drug-induced renal toxicity: Opportunities and challenges.
    Nassirpour R; Ramaiah SK; Whiteley LO
    Toxicol Appl Pharmacol; 2016 Dec; 312():34-41. PubMed ID: 26827821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.